Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition
McKenzie Crist, Benyamin Yaniv, Sarah Palackdharry, et al.
Journal for ImmunoTherapy of Cancer (2022) Vol. 10, Iss. 11, pp. e005632-e005632
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Metformin: update on mechanisms of action and repurposing potential
Marc Foretz, Bruno Guigas, Benoı̂t Viollet
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 460-476
Open Access | Times Cited: 339
Drug repurposing for cancer therapy
Ying Xia, Ming Sun, Hai Huang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Metformin and cancer hallmarks: shedding new lights on therapeutic repurposing
Hua Yu, Yue Zheng, Yiran Yao, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Chemoimmunotherapeutic Nanogel for Pre- and Postsurgical Treatment of Malignant Melanoma by Reprogramming Tumor-Associated Macrophages
Lu Tang, Cong Fu, Hening Liu, et al.
Nano Letters (2024) Vol. 24, Iss. 5, pp. 1717-1728
Closed Access | Times Cited: 16
Metformin and Its Immune-Mediated Effects in Various Diseases
Ichiro Nojima, Jun Wada
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 755-755
Open Access | Times Cited: 27
Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759
Marc Pujalte‐Martin, Amine Belaïd, Simon Bost, et al.
Molecular Oncology (2024) Vol. 18, Iss. 7, pp. 1719-1738
Open Access | Times Cited: 15
Metformin boosts antitumor immunity and improves prognosis in upfront resected pancreatic cancer: an observational study
Casper W.F. van Eijck, Disha Vadgama, Casper H.J. van Eijck, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 8, pp. 1374-1383
Open Access | Times Cited: 10
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management
Giuseppina Gallucci, Mario Larocca, Alessandro Navazio, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 334-334
Open Access | Times Cited: 1
Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy
Sara Fanijavadi, Mads Thomassen, Lars Henrik Jensen
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 515-515
Open Access | Times Cited: 1
Variações na Captação de FDG Miocárdica e Uso de Metformina: Implicações para a Sobrevida Durante a Imunoterapia
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access | Times Cited: 1
The Anti-Aging Mechanism of Metformin: From Molecular Insights to Clinical Applications
Ting Zhang, Zhou Li-jun, Meagan J. Makarczyk, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 816-816
Open Access | Times Cited: 1
The Impact of Metformin on Tumor-Infiltrated Immune Cells: Preclinical and Clinical Studies
Mohamed Abdelmoneim, Mona Alhussein Aboalela, Yoshinori Naoe, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13353-13353
Open Access | Times Cited: 22
Metformin Suppresses Both PD-L1 Expression in Cancer Cells and Cancer-Induced PD-1 Expression in Immune Cells to Promote Antitumor Immunity
Su Hwan Park, J.H. Lee, Hye Jin Yun, et al.
Annals of Laboratory Medicine (2024) Vol. 44, Iss. 5, pp. 426-436
Open Access | Times Cited: 6
Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review
Fereshtehsadat Jalali, Fatemeh Fakhari, Afrah Sepehr, et al.
Translational Oncology (2024) Vol. 45, pp. 101946-101946
Open Access | Times Cited: 6
Advancements in Cancer Immunotherapies
Ruchi Roy, Sunil Kumar Singh, Sweta Misra
Vaccines (2022) Vol. 11, Iss. 1, pp. 59-59
Open Access | Times Cited: 27
Metformin impacts the differentiation of mouse bone marrow cells into macrophages affecting tumour immunity
Andrea Scafidi, Frida Lind‐Holm Mogensen, Eleonora Campus, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37792-e37792
Open Access | Times Cited: 5
Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors
Jinhai Shen, Xinqi Ye, Hui Hou, et al.
International Immunopharmacology (2024) Vol. 134, pp. 112243-112243
Closed Access | Times Cited: 4
Bibliometric analysis of metformin as an immunomodulator (2013–2024)
Tongyi Zhou, Yunfeng Yu, Qi Li, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Variations in Myocardial FDG Uptake and Metformin Use: Implications for Survival during Immunotherapy
Matheus Coelho Torres, Juliana Góes Martins Fagundes, Luís Fábio Barbosa Botelho, et al.
ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR (2025) Vol. 38, Iss. 1
Open Access
Drug functional remapping: a new promise for tumor immunotherapy
Jiayi Dong, Ting Su, Jun Wu, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Tumor microenvironment-driven resistance to immunotherapy in non-small cell lung cancer: strategies for Cold-to-Hot tumor transformation
Jing-Lu Yu, Xiaoni Kong, Yu Feng
Cancer Drug Resistance (2025)
Open Access
Immunomodulatory effects of calorie restriction and its mimetics: new potential therapeutic approach for autoimmune diseases
Monokesh Kumer Sen, Eileen Liao, Duan Ni, et al.
Pharmacological Reviews (2025), pp. 100063-100063
Closed Access
NK cell based immunotherapy against oral squamous cell carcinoma
Ying Zhang, Jianming Xie, Haoran Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
AIM2 promotes the progression of HNSCC via STAT1 mediated transcription and IL-17/MAPK signaling
Dong Ding, Hongfei Liu, Liping Zhang, et al.
Cellular Signalling (2024) Vol. 127, pp. 111545-111545
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top